GlassScriptPhysician profile
Aurea Yadith Cordero
NPI 1215462411
$16,014.85
in general payments reported to CMS, 2019-2025
54 companies · $3,802 in 2025
The $3,802 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,234 · 2022: $3,284 · 2023: $1,803 · 2024: $2,891 · 2025: $3,802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,332 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,332.14 |
| Education | $164.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,388.07 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Mannkind Corporation | $1,284.77 | 2021-2025 | Afrezza |
| Astrazeneca Pharmaceuticals LP | $1,156.54 | 2021-2025 | Lokelma |
| Medtronic, INC. | $885.44 | 2021-2025 | Minimed 780g, Minimed 770g |
| Xeris Pharmaceuticals, INC. | $879.34 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Esperion Therapeutics, INC. | $879.20 | 2021-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $840.21 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $804.97 | 2021-2025 | Jardiance, Tradjenta |
| Insulet Corporation | $719.50 | 2021-2025 | Omnipod, Omnipod |
| Abbvie INC. | $686.74 | 2021-2025 | |
| Amgen INC. | $670.71 | 2021-2025 | Evenity, Prolia, Prolia |
| Opko Pharmaceuticals, LLC | $592.89 | 2021-2025 | Rayaldee |
| Sanofi-Aventis U.S. LLC | $585.83 | 2021-2023 | |
| Corcept Therapeutics | $490.37 | 2021-2024 | Korlym |
| Abbott Laboratories | $400.51 | 2022-2025 | Freestyle Libre 3 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $382.20 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Alkermes, INC. | $323.58 | 2024-2025 | Lybalvi, Aristada, Vivitrol |
| Dexcom, INC. | $263.48 | 2024-2025 | Dexcom G6 Transmitter |
| Recordati_rare_diseases_inc. | $227.69 | 2025 | Isturisa |
| Radius Health, INC. | $221.75 | 2022-2025 | Tymlos |
| Otsuka America Pharmaceutical, INC. | $206.18 | 2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Teva Pharmaceuticals USA, INC. | $193.14 | 2024-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Janssen Pharmaceuticals, INC | $191.97 | 2024-2025 | Invega Sustenna |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.99 | 2022-2024 | Xifaxan |
| Amarin Pharma, INC. | $168.95 | 2021-2023 | |
| Lundbeck LLC | $126.37 | 2024-2025 | Rexulti |
| Aimmune Therapeutics, INC. | $124.74 | 2025 | Zenpep |
| Sequel Med Tech, LLC | $117.70 | 2025 | Twiist |
| Antares Pharma, INC. | $114.01 | 2021-2024 | Xyosted |
| Beta Bionics, INC. | $108.85 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| E.R. Squibb & Sons, L.L.C. | $83.82 | 2025 | Cobenfy |
| Astellas Pharma US INC | $81.99 | 2025 | |
| Neurocrine Biosciences, INC. | $76.49 | 2024-2025 | Ingrezza |
| Becton, Dickinson and Company | $55.08 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.09 | 2024-2025 | Caplyta |
| Halozyme INC | $35.32 | 2023 | |
| Braeburn INC. | $34.88 | 2024-2025 | Brixadi |
| Amphastar Pharmaceuticals, INC. | $34.61 | 2024-2025 | |
| Cequr Corporation | $33.72 | 2021-2023 | Cequr Simplicity |
| Merck Sharp & Dohme LLC | $33.57 | 2022 | |
| Bigfoot Biomedical INC | $33.49 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.25 | 2023 | |
| Axsome Therapeutics, INC. | $26.91 | 2025 | Auvelity |
| Embecta Corp. | $23.32 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Averitas Pharma INC. | $23.03 | 2024 | Qutenza |
| Tandem Diabetes Care, INC. | $22.30 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $20.08 | 2025 | |
| Nestle Healthcare Nutrition INC. | $19.53 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.90 | 2024 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $15.41 | 2021 | |
| Amneal Pharmaceuticals LLC | $15.22 | 2021 | |
| Bausch Health US, LLC | $13.94 | 2025 | Aplenzin |
| Acella Pharmaceuticals, LLC | $13.93 | 2025 | NP Thyroid 60 |
| Vifor Pharma, INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aurea Cordero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.